Extra-pleural pneumonectomy in the setting of tri-modality therapy for patients with malignant pleural mesothelioma
Abstract
Although declining in the US due to restrictions of asbestos exposure, malignant pleural mesothelioma (MPP) remains a very serious thoracic malignancy that is rising in incidence worldwide (1).